Walking Fish Therapeutics

Mission Bio Inc, based in South San Francisco, specializes in single-cell genomics, offering advanced solutions for oncology research, including applications in precision medicine, biomarker development, and cell and gene therapy. Their Tapestri Platform enables comprehensive analysis of single-cell genetic variations, such as SNVs and CNVs, catering to hematologic malignancies like multiple myeloma and acute myeloid leukemia. The company focuses on providing innovative assay development services for both drug development and cell and gene therapy, reinforcing its commitment to advancing healthcare through cutting-edge genomic technologies. With a strong emphasis on uncovering clonal heterogeneity, Mission Bio is positioned at the forefront of precision medicine and cancer research. Generated from the website

Dice Therapeutics, Inc is a biopharmaceutical company based in South San Francisco, CA, dedicated to developing innovative oral medicines for autoimmune and inflammatory diseases. With a focus on biologically validated targets in immunology, they are building a robust pipeline of high-impact oral therapeutic candidates, including their lead program targeting the IL-17 cytokine for psoriasis and other IL-17 mediated diseases. Driven by a passion for innovation and backed by extensive experience in small molecule drug discovery and development, Dice Therapeutics aims to revolutionize the treatment landscape for chronic autoimmune and inflammatory diseases. Their DELSCAPE platform is designed to identify selective oral small molecules that modulate protein-protein interactions as effectively as systemic biologics, offering more convenient and accessible treatment options for patients.Generated from the website

SonoThera Inc., located in South San Francisco, is pioneering an ultrasound-mediated nonviral gene therapy platform aimed at delivering next-generation genetic medicines to various human organs. Their innovative technology seeks to address significant challenges in gene therapy, including safety, efficacy, biodistribution, and cost-effectiveness. With a focus on sonoporation, which has shown success in both preclinical and clinical settings, SonoThera is uniquely positioned to develop advanced gene therapies. The company's team is dedicated to building the future of gene therapy, leveraging their expertise to unlock the potential of genetic medicine. Generated from the website